The challenge of accurately detecting SNPs has long plagued molecular biology and diagnostic fields because subtle nucleotide differences often evade conventional probe designs. Traditional RNA probes and amplification methods frequently suffer from leakage, extended reaction times, and limited multiplexing capabilities, thereby constraining their clinical applicability. FARSIGHTs overcome these obstacles by integrating programmable aptamer components within RNA switches. Aptamers, evolving as nucleic acid sequences with high affinity and specificity for target molecules, here function as the sensitive elements of the switch, enabling real-time reporting upon target recognition.

The conceptual design behind FARSIGHT probes was accomplished through computational, or in silico, methods. This approach meticulously tailors the RNA structure to ensure tight sequence-specific recognition while maintaining stability under physiological conditions. Functional efficacy hinges on the probe’s ability to undergo conformational changes in response to single nucleotide mismatches, which significantly influence the switch’s fluorescence output. The result is a system capable of discerning even a solitary base change within complex nucleic acid populations—a feat that surpasses many existing technologies in sensitivity and rapidity.

A remarkable feature of FARSIGHT is its ultra-fast activation kinetics. The probes exhibit measurable fluorescence signals within as little as five minutes, a substantial improvement over standard molecular diagnostics where detection times can span hours. This swift reporting occurs independently from any upstream nucleic acid amplification steps, thereby enabling more flexible and time-efficient workflows. Such rapid turnaround is particularly advantageous in clinical settings where timely decision-making can influence patient outcomes or contain infectious outbreaks.

When paired with isothermal amplification techniques—a method that amplifies DNA or RNA at a constant temperature without the need for thermal cycling—FARSIGHTs demonstrate extraordinary sensitivity. This synergy facilitates the detection of single nucleotide mutations at attomolar concentrations, reflecting extraordinarily low copy numbers of target sequences. The strong fluorescence response at such minuscule concentrations not only signifies the probe’s high signal-to-noise ratio but also translates into potential applications for detecting rare mutations that are often clinically relevant.

To demonstrate the real-world applicability of this technology, the research team employed FARSIGHT probes to distinguish between multiple variants of concern of the SARS-CoV-2 virus. Specifically, the probes accurately differentiated the Omicron variant from the Alpha, Beta, and Gamma strains using RNA extracted directly from clinical saliva samples. The ability to discriminate variants with absolute accuracy in such non-invasive samples highlights the potential for point-of-care diagnostic tools that can rapidly inform public health responses and treatment protocols.

Besides viral detection, FARSIGHTs hold immense promise for personalized healthcare, wherein genotyping an individual’s genetic makeup influences therapy choices. Unlike traditional techniques requiring complex instrumentation or extensive processing, these RNA switches can be programmed easily and reconfigured for evolving pathogenic threats or new mutations. This adaptability ensures sustained relevance of the technology as genomic landscapes change due to natural genetic drift or selective pressure from treatment interventions.

The methodological rigor underpinning FARSIGHT design further embodies a sophisticated interplay between computational biology and synthetic nucleic acid chemistry. Detailed in silico simulations preemptively evaluate probe folding, target hybridization dynamics, and fluorescence emission parameters. Such computational vetting reduces experimental trial-and-error phases, accelerates development timelines, and provides a blueprint for designing bespoke probes against a wide array of genetic targets.

Technically, the mechanism of FARSIGHT activation is predicated on an unstable aptamer configuration in the absence of the exact complementary target sequence. Upon hybridization with perfectly matching target RNA strands bearing a specific nucleotide at the single base site, the structure stabilizes, triggering a conformational rearrangement that activates a fluorescent reporter molecule embedded within the RNA sequence. Conversely, single nucleotide mismatches fail to induce sufficient structural stabilization, thus preventing probe activation and minimizing false-positive signals.

This elegant design principle addresses a pervasive challenge in genotyping assays—leakage, or unintended signal generation even without target binding. By tuning the aptamer’s sensitivity and the probe’s thermodynamic properties, FARSIGHTs significantly curtail background fluorescence, enhancing both diagnostic accuracy and user confidence. Moreover, the multiplexing capability allows simultaneous detection of multiple SNPs within a single assay, improving throughput and conserving precious biological samples.

Expanding beyond infectious disease diagnostics, the implications for monitoring genetic disorders are vast. Many inherited diseases, cancers, and drug response variations hinge upon specific point mutations within critical genes. Traditional genotyping methods often lack the speed or sensitivity required for timely, actionable results. By contrast, FARSIGHT probes furnish a platform capable of revealing such mutations promptly, even when present at exceedingly low frequencies amidst a backdrop of wildtype sequences.

From a public health perspective, the ability to rapidly genotype pathogens with single nucleotide resolution can dramatically influence outbreak containment strategies. Identifying variants harboring drug resistance mutations or increased transmissibility within minutes rather than days could inform targeted quarantines, vaccine updates, and therapeutic adjustments. FARSIGHT technology could thereby serve as an indispensable tool during emerging infectious disease crises or routine surveillance programs.

Importantly, the straightforward operational requirements and programmability of FARSIGHTs suggest their amenability for integration into portable diagnostic devices. Such point-of-care platforms could empower frontline healthcare workers and remote regions lacking sophisticated laboratory infrastructure. By delivering immediate genetic insights at the bedside or community level, this technology aligns with current trends toward decentralized, precision medicine approaches.

Looking forward, ongoing research will likely explore further optimization of FARSIGHT probes for broader sequence coverage, expanded chemical modifications to enhance stability, and integration with microfluidic systems for automated workflows. The scalability of probe synthesis combined with advances in fluorescence detection hardware positions this approach well for commercialization and widespread adoption across clinical and research domains.

In essence, FARSIGHT aptamer-based RNA switches embody a transformative leap in molecular diagnostics, marrying the nuances of nucleic acid biochemistry with cutting-edge computational design. Their ability to rapidly, accurately, and sensitively detect single nucleotide changes paves the way for a new generation of diagnostic assays that meet the urgent demands of modern medicine and epidemiology. As this technology matures, it promises to empower clinicians, researchers, and public health officials with unprecedented genomic resolution at speeds required for effective intervention and personalized treatment plans.

Subject of Research:
Programmable RNA-based aptamer switches for high-precision detection of single nucleotide polymorphisms.

Article Title:
Programmable fluorescent aptamer-based RNA switches for rapid identification of point mutations

Article References:
Yan, Z., Li, Y., Eshed, A. et al. Programmable fluorescent aptamer-based RNA switches for rapid identification of point mutations. Nat. Chem. (2025). https://doi.org/10.1038/s41557-025-01995-6

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41557-025-01995-6

The study meticulously develops a robust statistical framework to predict the geometric configuration of the bony structures of hands and feet. By employing sophisticated algorithms, the researchers were able to analyze a vast dataset of anatomical scans, allowing them to create detailed models of skeletal geometry. The use of statistical shape modeling (SSM) techniques enables a comprehensive understanding of shape variance, providing insights into how individual anatomy can differ even within a seemingly uniform population. This is particularly relevant in fields such as personalized medicine, where tailored interventions could substantially enhance patient outcomes.

This research contributes to a wider understanding of how anatomical diversity affects clinical practices. Standard models of hand and foot anatomy often overlook significant variations found in different populations. By focusing on the skeletal topology, the authors aim to improve anthropometric data that is essential for the design of medical devices, including customized implants and orthoses. This shift toward individualized designs can be fundamental in addressing the intricate requirements of patients who exhibit unique anatomical features.

The foundation of this study lies in a well-defined methodological approach that involves data acquisition, shape modeling, and statistical analysis. The researchers employed a diverse cohort for their data collection, ensuring that the resulting models reflect a wide range of anatomical variations. By integrating machine learning with traditional shape analysis, the team has pioneered a method that not only captures complex shapes but also predicts the likelihood of specific anatomical configurations. This dual approach paves the way for more dynamic and flexible modeling techniques that can be applied across various applications in medical science.

One of the key advantages of utilizing statistical shape models is the ability to visualize and comprehend complex shape interactions better. For the hand and foot, where bone structure intricately relates to functional movement, understanding these geometric nuances is essential. The statistical framework employed in this research results in a three-dimensional representation of bony structures that can aid surgeons and clinicians in pre-operative planning. Moreover, these models can help in identifying potential issues prior to surgical interventions, ultimately leading to safer and more effective procedures.

In conjunction with the technical advancements, the study also emphasizes the significance of collaboration between engineering and medical fields. By fostering interdisciplinary partnerships, researchers can harness the power of computational modeling, machine learning, and clinical insight to enhance healthcare delivery. This integrated approach is particularly relevant in the context of developing adaptive prosthetic devices that mimic natural movement patterns. By closely aligning device design with anatomical insights, engineers can create solutions that significantly improve the quality of life for individuals with limb differences.

Furthermore, the implications of this research extend beyond clinical realms into educational settings. By understanding the skeletal variations and their implications, educators can better prepare future medical professionals to address the complexities of human anatomy. This study serves as a stepping stone for future research initiatives aimed at enhancing anatomical education, ensuring that upcoming generations of healthcare practitioners possess an in-depth understanding of human variability.

Despite the promising insights gained from this research, the authors acknowledge the limitations inherent in their study. As with any statistical model, there exists a certain level of unpredictability when applying these findings to individual cases. Future work will focus on refining these models to account for additional variables such as age, gender, and health status, which can all substantially influence skeletal geometry. By continuously updating and validating these models against real-world data, researchers can enhance their reliability and applicability in clinical settings.

The exploration of bony geometry through statistical shape modeling also opens avenues for clinical research focused on various musculoskeletal disorders. Conditions such as arthritis, osteoporosis, and congenital anomalies can profoundly affect skeletal structure and function. By leveraging the methods developed in this study, clinicians could develop predictive models that identify at-risk individuals earlier in their treatment journey. This proactive approach could transform patient care, enabling timely interventions and personalized therapy plans based on predictive analytics.

In summary, the work by Duquesne et al. signifies a pivotal shift in how medical and engineering fields can converge to tackle challenges associated with anatomical variability. Through statistical shape modeling, researchers have not only advanced our understanding of skeletal geometry but have also laid the groundwork for future innovations in personalized medicine, surgical planning, and educational practices. As the landscape of healthcare continues to evolve, integrating these sophisticated modeling techniques will be crucial in optimizing patient care.

Ultimately, this research represents a vibrant intersection of technology and biology, showcasing how interdisciplinary collaboration can lead to unprecedented advancements in understanding human anatomy and improving health outcomes. By embracing this innovative approach, the medical community can expect significant breakthroughs in not just how we treat skeletal issues but also in fostering a comprehensive understanding of the complex interplay between form and function within the human body.

As the study unfolds and its insights are further explored, the potential for translating these findings into clinical practice seems boundless. The emphasis on precision and individualization aligns flawlessly with the trend towards tailored healthcare solutions, making statistical shape modeling a promising frontier in biomedical engineering.

Subject of Research: Statistical Shape Modeling for Hand and Foot Bony Geometry

Article Title: From Skin to Skeleton: A Statistical Shape Modelling Approach for Predicting Hand and Foot Bony Geometry

Article References:

Duquesne, K., Molnar, A., Huysentruyt, R. et al. From Skin to Skeleton: A Statistical Shape Modelling Approach for Predicting Hand and Foot Bony Geometry. Ann Biomed Eng (2025). https://doi.org/10.1007/s10439-025-03882-0

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s10439-025-03882-0

Keywords: Statistical Shape Modeling, Bony Geometry, Hand, Foot, Personalized Medicine, Clinical Applications, Biomedical Engineering.

MetaKSSD represents a significant leap forward in the scalability of MarkerDB and the efficiency of metagenomic profiling. At its core, the innovation lies in its use of sketch operations, a method that enhances the ability of MarkerDB to grow without demanding enormous storage resources. With just 0.17 GB of storage, MetaKSSD encompasses a staggering 85,202 species, indicating not just a qualitative improvement in the database but a quantitative one as well.

Performance metrics reveal that MetaKSSD can profile up to 10 GB of data in mere seconds. This speed is crucial, particularly in the context of rapidly advancing fields such as personalized medicine and microbiome research. The ability to process vast amounts of data can transform the landscape of scientific inquiry, allowing for instantaneous analysis and decision-making based on real-time data.

Importantly, one of the standout features of MetaKSSD is its impressive profiling accuracy. Leveraging its extensive MarkerDB, this tool has exhibited a marked improvement in profiling outcomes compared to existing applications like MetaPhlAn4. This level of performance is particularly beneficial for microbiome-phenotype association studies, where the identification of nuances can lead to groundbreaking insights into the role of microbial communities in human health and disease.

In a recent application, MetaKSSD’s capabilities were put to the test with an impressive analysis of 382,016 metagenomic runs. This unprecedented scale of profiling not only reinforces the utility of the tool but also enables researchers to discern patterns and associations that may have previously remained hidden due to data overload or analytical limitations.

The utility of MetaKSSD extends beyond mere data analysis. By facilitating extensive sample clustering analyses, researchers have been able to identify potential niches that have yet to be explored. This opens up new avenues for discovery, positioning researchers at the cutting edge of microbial ecology and related fields.

In addition to its analytical capabilities, MetaKSSD offers a user-friendly interface that allows for immediate searches of similar profiles. This feature is particularly significant for non-expert users keen on delving into metagenomic data without requiring in-depth training in bioinformatics. By bridging the gap between complex data and accessible insights, MetaKSSD empowers a broader audience to engage in metagenomic research.

The implications of this technology are far-reaching, touching diverse domains such as environmental biology, clinical research, and public health. For instance, in environmental biology, the monitoring of microbial communities can inform biodiversity assessments and ecosystem health evaluations. Meanwhile, in the clinical arena, understanding the microbiome’s interaction with human health could lead to new therapeutic strategies and interventions.

The innovative nature of MetaKSSD is underscored by the creative use of sketch operations, a method that allows for efficient handling of large datasets. By summarizing complex information into compact representations, sketch operations enable quick retrieval and analysis without compromising the richness of the data. This innovation not only enhances scalability but also positions MetaKSSD as a pioneering tool in the ongoing evolution of metagenomic analysis.

With this development, the landscape of metagenomic profiling is on the cusp of transformation. As researchers continue to explore the vast microbial world, tools like MetaKSSD will be essential in bridging the growing divide between data generation and actionable insights. The capability to analyze large datasets swiftly and accurately will not only expedite research but also amplify the potential for discoveries that can have profound implications on health, ecology, and our understanding of complex biological systems.

As the volume of genetic data continues to explode, the importance of having scalable, efficient tools like MetaKSSD cannot be overstated. The combination of rapid processing capabilities and extensive species representation enables researchers to conduct large-scale studies that were previously impractical. The future of metagenomics is here, and it’s powered by innovations such as MetaKSSD, setting a precedent that will likely influence research methodologies and tools for years to come.

MetaKSSD is not just an upgrade; it’s a reinvention of how we approach the complexities of the microbial world. Researchers adept in the nuances of microbiome studies will find in MetaKSSD a tool that not only meets their needs but exceeds them, enabling a level of detail and breadth in data analysis that was previously unattainable. It heralds an era where non-experts can also engage deeply with metagenomic data, forging connections and developing insights that could change our understanding of microbiomes in health, ecology, and beyond.

In conclusion, the development of MetaKSSD marks a pivotal moment in the field of metagenomics. By innovating how MarkerDB is constructed and utilized, this tool enhances not only the scalability of databases but also the accuracy and performance of metagenomic profiling. The future of microbial research is bright, fueled by technological advancements that make the study of complex biological systems more accessible and efficient than ever before.

Subject of Research: Metagenomic Profiling and Database Construction

Article Title: MetaKSSD: boosting the scalability of the reference taxonomic marker database and the performance of metagenomic profiling using sketch operations.

Article References:

Yi, H., Lu, X. & Chang, Q. MetaKSSD: boosting the scalability of the reference taxonomic marker database and the performance of metagenomic profiling using sketch operations.
Nat Comput Sci (2025). https://doi.org/10.1038/s43588-025-00855-0

Image Credits: AI Generated

DOI:

Keywords: Metagenomics, Microbial Profiling, MarkerDB, Bioinformatics, Sketch Operations

The significance of accurate liver tumor segmentation cannot be overstated. Precise delineation of tumors is crucial for effective treatment planning, which often includes surgical resection, radiation therapy, or transarterial chemoembolization. Traditional methods of tumor segmentation often fall short in terms of accuracy and reliability, leaving a critical gap that RFiLM U-Net aspires to fill. This new model leverages advanced machine learning techniques to deliver comprehensive insights that are essential in the context of personalized medicine.

At the core of the RFiLM U-Net is the integration of radiomic features, which pertain to quantitative data extracted from medical images. Radiomics is an emerging field that utilizes high-throughput methods to decode the phenotypic characteristics of tumors, thereby providing valuable prognostic and predictive information. By harnessing these features, the RFiLM U-Net aims to enhance the segmentation process, allowing for a more effective analysis of tumor morphology and heterogeneity.

The underlying architecture of the RFiLM U-Net employs a unique linear modulation approach that refines the images used for tumor identification. This model not only processes the visual data more effectively but also aids in minimizing uncertainty, which is a common challenge faced in imaging diagnostics. The innovative structure functions by modulating the information flow within the neural network, leading to more robust feature representations, ultimately translating to improved segmentation accuracy.

One of the study’s pivotal aspects is its validation phase, where the researchers tested the RFiLM U-Net against conventional segmentation models. The results demonstrated that the new framework significantly outperformed existing methodologies in terms of both segmentation accuracy and computational efficiency. Such a leap in performance reflects the promising future of integrating advanced artificial intelligence techniques into the domain of medical imaging.

Furthermore, the researchers highlighted the model’s ability to generalize across various imaging modalities, including CT and MRI scans. This versatility is of paramount importance as it suggests that the RFiLM U-Net could be deployed in a wide array of clinical settings, ultimately benefiting a larger patient population. The adaptability of this model underscores the potential for wider application in oncological practices aimed at improving patient care.

The clinical implications of this research extend far beyond mere segmentation enhancements. The increased accuracy in tumor delineation fosters better treatment planning, thereby improving prognostic outcomes for patients. This could lead to more tailored therapeutic approaches, where interventions are closely aligned with the specific tumor characteristics discerned through advanced imaging techniques.

Moreover, the RFiLM U-Net model facilitates a more thorough assessment of tumor response to treatment over time. By employing this model in longitudinal studies, clinicians can better track the effectiveness of various therapeutic strategies based on real-time evaluation of tumor dynamics. This could serve as a game-changer in the field of oncology, leading to more effective interventions and improved quality of life for patients.

As the research community continues to explore the extensive landscape of artificial intelligence in medicine, studies such as these are indicative of the bright prospects that lie ahead. By refining methodologies for tumor segmentation, scientists can pave the way for smart technologies that enhance decision-making in diagnostics and treatment. The RFiLM U-Net illustrates this potential, shining a light on how integration of computing power and medical expertise can yield significant advancements in health outcomes.

The successful application of the RFiLM U-Net raises a pertinent question about the future of medical imaging. As clinicians, researchers, and technologists collaborate more closely, the possibilities for advancement become virtually limitless. The innovation showcased in this study may spur additional research aimed at further integrating AI-driven solutions into medical practices, ultimately leading to a paradigm shift in how tumors are diagnosed and treated.

In conclusion, the development of the RFiLM U-Net marks a significant milestone in the field of liver tumor segmentation, combining the strengths of radiomics and machine learning to achieve outstanding performance. By prioritizing precision and adaptivity, this framework offers immense promise for enhancing clinical practices and patient care. As such, it stands as an exemplary model for future research endeavors focused on integrating artificial intelligence in medicine, where the confluence of technology and healthcare continues to forge new paths toward improving patient outcomes.

The work represented in this innovative study not only contributes to the academic field but also carries the potential to dramatically transform clinical practices in oncology. As we stand on the brink of a new era in medical imaging, it is imperative that we continue to foster and support such initiative-driven research to fully realize the capabilities of modern technology in enhancing healthcare delivery.

Subject of Research: Radiomic Feature-Integrated Linear Modulation Network for Precise Liver Tumor Segmentation

Article Title: RFiLM U-Net: Radiomic Feature-Integrated Linear Modulation Network for Precise Liver Tumor Segmentation

Article References:

Tsai, LW., Agrawal, A., Dash, P. et al. RFiLM U-Net: Radiomic Feature-Integrated Linear Modulation Network for Precise Liver Tumor Segmentation.
J. Med. Biol. Eng. 45, 177–186 (2025). https://doi.org/10.1007/s40846-025-00938-3

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s40846-025-00938-3

Keywords: Liver Tumor, RFiLM U-Net, Radiomics, Machine Learning, Medical Imaging, Tumor Segmentation.

Detailed in a recent article published in the prestigious journal Science, this groundbreaking technology is the brainchild of Dr. Luke Cox, an innovator who transitioned from a student at the University of Bristol to the CEO of the newly minted company, Impulsonics. This publication, a prize-winning essay featured in the Bioinnovation Institute and Science Prize for Innovation, details Dr. Cox’s journey and the technology’s development.

Currently, the process of drug development is cumbersome and essential. It requires countless hours and significant resources, primarily as scientists culture cells in petri dishes to conduct various tests. Surprisingly, in 2025, this intricate procedure persists as an arduous task resistant to automation, leading to high costs and the potential for inaccuracies in drug development aimed at saving lives.

The breakthrough at Impulsonics utilizes the properties of acoustic waves to manipulate cells in a way that appears almost magical. The cells move as if dancing, demonstrating this capricious behavior without requiring the traditional, cumbersome equipment found in biomedical labs. This capability streamlines automation processes related to cell culture, vastly improving the speed and efficiency of drug discovery.

Dr. Cox initially became fascinated by the physics of acoustic levitation, where he created a groundbreaking experiment capable of suspending objects in mid-air against the force of gravity. His observations during this experiment illuminated the possibility of harnessing such technology for delicate operations involving small biological entities like cells. What started as a curiosity with levitating diamonds soon evolved into a vision for redesigning how laboratories operate, paving the way for Impulsonics.

The transformative technology developed by Luke and his dedicated team has advanced to the stage where complex biomedical tasks, such as expanding cell populations, are not only feasible but also executed far more efficiently than before. Dr. Cox emphasized the significant advantages of their technology, notably its ability to hasten the screening process of new drugs. This swift capability can accelerate the identification of new therapies for a multitude of diseases, including those as challenging as cancer and Alzheimer’s.

Furthermore, Professor Bruce Drinkwater, a collaborator and co-founder of Impulsonics, expressed his enthusiasm regarding the physical attributes of the device, which boasts a relatively small footprint—approximately half the size of a conventional laboratory bench. In stark contrast to previous technologies that required entire rooms, this compact device’s agility allows for seamless integration into existing laboratory infrastructures while ensuring a rapid yield of high-quality data, a critical demand in biomedical research.

Looking ahead, the potential applications for this pioneering invention stretch beyond the boundaries of traditional biotechnology. The device’s ability to accurately manipulate cells vows to influence various sectors within the pharmaceutical industry, from foundational research to clinical applications. Dr. Cox concluded by expressing his excitement for the future of this unique technology platform and its promise to expedite advancements across pharmaceutical and healthcare fields, particularly wherever the growth of cells is involved.

Given the competitive landscape of medical research, the contributions of this technology can potentially redefine standards for bioengineering and drug development. Scientists have historically labored under the constraints of meticulous laboratory protocols, but now, the introduction of acoustic manipulation could usher in an era characterized by expedited drug synthesis and evaluation. The ease of automation may see an unprecedented rate of medicinal discoveries, promising life-altering advancements for patients worldwide.

Ultimately, the marriage of acoustic technology with cellular biology has the potential to become a game changer, allowing researchers to shift from outdated methodologies to more agile and effective practices. As the fields of biotechnology and pharmaceuticals evolve, this promising innovation represents a significant stride towards enhancing the efficiency and effectiveness of the drug discovery process.

The vision laid out by Dr. Cox and his team could soon lead to a transformative leap in how modern medicine approaches patient health. As personalized medicine becomes an increasingly pivotal conversation within healthcare, this technology stands ready to equip clinicians with the tools they need to tailor drug therapies to individual patients, thereby maximizing efficacy and minimizing unwanted side effects. As the scientific community eagerly anticipates further developments, it is clear that the technology birthed from the University of Bristol holds immense promise and potential for a healthier tomorrow.

Subject of Research: Acoustic Manipulation of Cells
Article Title: Revolutionizing Drug Discovery: Acoustic Manipulation of Cells
News Publication Date: [Date not provided]
Web References: [Not available]
References: [Not available]
Image Credits: Impulsonics Ltd

Keywords

Acoustic technology, drug discovery, personalized medicine, biomedical research, cell manipulation, University of Bristol, Impulsonics, Science journal, innovation in healthcare.